AIM Vaccine Revenue

AIM Vaccine had revenue of 537.18M CNY in the half year ending June 30, 2024, a decrease of -9.19%. This brings the company's revenue in the last twelve months to 1.18B, down -2.37% year-over-year. In the year 2023, AIM Vaccine had annual revenue of 1.19B, down -6.06%.

Revenue (ttm)

1.18B CNY

Revenue Growth

-2.37%

P/S Ratio

3.78

Revenue / Employee

729.17K CNY

Employees

1,624

Market Cap

4.81B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.19B	-76.61M	-6.06%
Dec 31, 2022	1.26B	-306.06M	-19.49%
Dec 31, 2021	1.57B	-67.84M	-4.14%
Dec 31, 2020	1.64B	686.32M	72.12%
Dec 31, 2019	951.65M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition